Schedule 13D ownership disclosure
Sucampo Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 864909106
Event date: 2013-11-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-14-280583
- Form type
- SC 13D
- Filer
- S&R Foundation
- CIK
- CIK 1614000
- Filed
- Jul 25, 2014
- Reporting period
- Nov 25, 2013
- Description
- Schedule 13D beneficial ownership